Interestingly, in the subgroup analysis limited to patients who were heterozygous at the HLA-B locus as described previously [18], we observed no significant association between HLA-B HED and other genomic features, such as CNA burden, TMB, and tumor neoantigen burden (TNB) (Additional file 3: Fig. S8). Here, HLA-B is linked to neoplasm.